Compare VALU & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VALU | MASS |
|---|---|---|
| Founded | 1931 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.4M | 324.4M |
| IPO Year | N/A | 2020 |
| Metric | VALU | MASS |
|---|---|---|
| Price | $37.55 | $5.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 3.1K | ★ 371.7K |
| Earning Date | 12-15-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | ★ 6.17 | N/A |
| EPS | ★ 2.26 | N/A |
| Revenue | $34,801,000.00 | ★ $65,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.55 |
| P/E Ratio | $16.85 | ★ N/A |
| Revenue Growth | N/A | ★ 36.21 |
| 52 Week Low | $32.94 | $1.81 |
| 52 Week High | $55.01 | $9.34 |
| Indicator | VALU | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 38.17 |
| Support Level | $37.07 | $6.26 |
| Resistance Level | $39.20 | $6.83 |
| Average True Range (ATR) | 0.81 | 0.38 |
| MACD | 0.23 | 0.04 |
| Stochastic Oscillator | 65.88 | 14.61 |
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.